GLYCOPYRROLATE

GLYCOPYRROLATE was reported 5651 times

GLYCOPYRROLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL LUNG CAPACITY INCREASED 139 0.5110
1 MALIGNANT MEDIASTINAL NEOPLASM 54 0.4909
2 HEART SOUNDS 47 0.4896
3 FUNGAL TEST 6 0.4615
4 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 197 0.3767
5 RHINITIS PERENNIAL 25 0.3125
6 PROLONGED EXPIRATION 69 0.2634
7 INFLAMMATORY MARKER TEST 6 0.2609
8 BRONCHIAL NEOPLASM 26 0.1912
9 OCCUPATIONAL EXPOSURE TO AIR CONTAMINANTS 8 0.1818
10 HYPER IGE SYNDROME 20 0.1754
11 CARBOXYHAEMOGLOBIN INCREASED 8 0.1333
12 EXPIRATORY RESERVE VOLUME DECREASED 8 0.1270
13 HAEMOPHILUS SEPSIS 6 0.1053
14 BRONCHIAL HAEMORRHAGE 26 0.0833
15 SMOKE SENSITIVITY 25 0.0812
16 LARYNGITIS FUNGAL 10 0.0775
17 NASAL TURBINATE HYPERTROPHY 29 0.0769
18 ENDOMETRIAL ABLATION 25 0.0700
19 ANORECTAL POLYP 6 0.0561
20 HUMIDITY INTOLERANCE 22 0.0550
21 ACCELERATED IDIOVENTRICULAR RHYTHM 7 0.0473
22 BLOOD IMMUNOGLOBULIN E INCREASED 101 0.0417
23 OROPHARYNGITIS FUNGAL 8 0.0396
24 PERFUME SENSITIVITY 22 0.0387
25 PARKINSONIAN REST TREMOR 7 0.0370
26 SPUTUM PURULENT 24 0.0365
27 BRACHIAL PLEXOPATHY 8 0.0362
28 FORCED EXPIRATORY VOLUME DECREASED 101 0.0356
29 NASAL POLYPS 174 0.0353
30 PULMONARY FUNCTION TEST ABNORMAL 55 0.0353
31 RHINITIS ALLERGIC 155 0.0348
32 BRONCHIAL WALL THICKENING 25 0.0348
33 BRONCHIAL HYPERREACTIVITY 41 0.0341
34 BRONCHIECTASIS 229 0.0340
35 BRONCHOSPASM PARADOXICAL 10 0.0332
36 PRECANCEROUS CONDITION 22 0.0328
37 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 65 0.0318
38 VITAL CAPACITY DECREASED 14 0.0312
39 NASAL MUCOSAL DISCOLOURATION 5 0.0311
40 LUNG DIFFUSION TEST DECREASED 12 0.0301
41 SARCOIDOSIS 140 0.0294
42 JAUNDICE CHOLESTATIC 104 0.0294
43 DUST ALLERGY 28 0.0285
44 ATRIOVENTRICULAR DISSOCIATION 6 0.0280
45 ADJUSTMENT DISORDER 36 0.0277
46 ORTHOSTATIC HYPERTENSION 16 0.0274
47 HYPOMANIA 99 0.0269
48 NAIL DYSTROPHY 14 0.0250
49 FORCED VITAL CAPACITY DECREASED 16 0.0245
50 OBSTRUCTIVE AIRWAYS DISORDER 272 0.0244
51 RHONCHI 32 0.0232
52 RESTRICTIVE PULMONARY DISEASE 27 0.0230
53 FULL BLOOD COUNT ABNORMAL 236 0.0223
54 VOLUME BLOOD DECREASED 9 0.0214
55 POSITIVE AIRWAY PRESSURE THERAPY 6 0.0205
56 FUNGAL PHARYNGITIS 5 0.0199
57 SPUTUM DISCOLOURED 180 0.0190
58 BRONCHIAL DISORDER 29 0.0186
59 INCREASED BRONCHIAL SECRETION 47 0.0184
60 PEAK EXPIRATORY FLOW RATE DECREASED 8 0.0182
61 INSPIRATORY CAPACITY DECREASED 5 0.0181
62 BREATH SOUNDS ABNORMAL 86 0.0174
63 BRONCHIAL SECRETION RETENTION 21 0.0165
64 BRONCHIAL OBSTRUCTION 23 0.0164
65 CARDIAC MURMUR 140 0.0162
66 PANCREATIC MASS 17 0.0159
67 ANISOCORIA 6 0.0159
68 NASAL DISCHARGE DISCOLOURATION 21 0.0152
69 GENITAL ABSCESS 6 0.0149
70 SUBRETINAL FLUID 16 0.0146
71 MATERNAL EXPOSURE DURING DELIVERY 14 0.0141
72 ISCHAEMIC CARDIOMYOPATHY 43 0.0140
73 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 227 0.0134
74 DEPRESSIVE SYMPTOM 47 0.0133
75 RALES 77 0.0132
76 POLYCYSTIC OVARIES 20 0.0129
77 STRESS CARDIOMYOPATHY 75 0.0129
78 WHEEZING 719 0.0121
79 TOTAL LUNG CAPACITY DECREASED 19 0.0119
80 SENSITISATION 9 0.0119
81 ABDOMINAL COMPARTMENT SYNDROME 7 0.0110
82 MITE ALLERGY 7 0.0107
83 DELAYED RECOVERY FROM ANAESTHESIA 10 0.0105
84 HEAT STROKE 16 0.0105
85 ENDOTRACHEAL INTUBATION COMPLICATION 6 0.0102
86 AXILLARY PAIN 15 0.0101
87 BODY TEMPERATURE ABNORMAL 18 0.0098
88 EOSINOPHIL COUNT INCREASED 78 0.0094
89 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 6 0.0093
90 LUNG HYPERINFLATION 8 0.0093
91 RESTING TREMOR 6 0.0093
92 BREAST CANCER RECURRENT 29 0.0092
93 RESPIRATION ABNORMAL 63 0.0091
94 LARYNGOSPASM 24 0.0089
95 HYPOVENTILATION 29 0.0089
96 METAMORPHOPSIA 16 0.0087
97 FOREARM FRACTURE 6 0.0086
98 DIPLEGIA 17 0.0086
99 SCHIZOPHRENIA 104 0.0085
100 ALCOHOL INTOLERANCE 6 0.0085
101 LOWER RESPIRATORY TRACT CONGESTION 14 0.0082
102 EMPHYSEMA 82 0.0081
103 RESPIRATORY SYMPTOM 23 0.0081
104 EOSINOPHIL COUNT ABNORMAL 6 0.0080
105 MUCOSAL DISCOLOURATION 5 0.0078
106 MITRAL VALVE CALCIFICATION 5 0.0078
107 OPISTHOTONUS 6 0.0075
108 ASTHMA 853 0.0075
109 APPETITE DISORDER 50 0.0075
110 GRANULOMA 26 0.0075
111 GRANULOMATOSIS WITH POLYANGIITIS 9 0.0075
112 BRONCHOPULMONARY DYSPLASIA 6 0.0075
113 PRODUCTIVE COUGH 350 0.0073
114 SENSITIVITY TO WEATHER CHANGE 37 0.0070
115 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 361 0.0069
116 PULMONARY CAVITATION 6 0.0069
117 ANGLE CLOSURE GLAUCOMA 17 0.0067
118 CHRONIC SINUSITIS 25 0.0067
119 ANAESTHETIC COMPLICATION NEUROLOGICAL 6 0.0066
120 ALLERGY TO ANIMAL 7 0.0066
121 ASTHMATIC CRISIS 24 0.0066
122 LUNG NEOPLASM 28 0.0065
123 SECRETION DISCHARGE 82 0.0065
124 PRODUCT APPEARANCE CONFUSION 6 0.0065
125 RHINITIS 52 0.0064
126 CATHETER SITE HAEMORRHAGE 16 0.0064
127 ANTICHOLINERGIC SYNDROME 10 0.0063
128 CONJUNCTIVITIS ALLERGIC 9 0.0061
129 SPUTUM RETENTION 6 0.0061
130 DROOLING 41 0.0059
131 ACUTE PULMONARY OEDEMA 33 0.0059
132 DYSPNOEA AT REST 17 0.0059
133 PULMONARY CONGESTION 77 0.0058
134 ENTEROVIRUS INFECTION 5 0.0058
135 PUPIL FIXED 10 0.0058
136 PULMONARY FUNCTION TEST DECREASED 25 0.0057
137 HYPOPERFUSION 6 0.0057
138 NASAL INFLAMMATION 6 0.0057
139 FLANK PAIN 53 0.0056
140 ANAEMIA OF CHRONIC DISEASE 5 0.0055
141 RESPIRATORY RATE INCREASED 49 0.0055
142 DYSPNOEA EXERTIONAL 204 0.0054
143 RESPIRATORY RATE DECREASED 17 0.0054
144 ANGIOPLASTY 8 0.0054
145 BLOODY DISCHARGE 6 0.0052
146 PAROTITIS 6 0.0052
147 HYPERTROPHIC CARDIOMYOPATHY 8 0.0052
148 STRIDOR 15 0.0051
149 MEGACOLON 8 0.0051
150 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 242 0.0050
151 SINUS OPERATION 12 0.0050
152 PULSELESS ELECTRICAL ACTIVITY 21 0.0050
153 MIDDLE INSOMNIA 93 0.0050
154 VASCULITIS 58 0.0050
155 CHANGE OF BOWEL HABIT 10 0.0049
156 HEPATOTOXICITY 106 0.0048
157 SPUTUM INCREASED 10 0.0046
158 SALIVARY HYPERSECRETION 46 0.0046
159 PNEUMONIA PSEUDOMONAL 7 0.0046
160 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 15 0.0045
161 VOCAL CORD PARALYSIS 8 0.0045
162 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 317 0.0045
163 RHINOVIRUS INFECTION 17 0.0044
164 PULMONARY MASS 63 0.0042
165 JAW FRACTURE 9 0.0042
166 SEASONAL ALLERGY 59 0.0042
167 RESPIRATORY DISORDER 124 0.0041
168 NASAL DISORDER 11 0.0041
169 DYSLIPIDAEMIA 21 0.0041
170 NASAL CONGESTION 241 0.0041
171 ANAESTHETIC COMPLICATION 11 0.0041
172 ECCHYMOSIS 28 0.0041
173 BLOOD BILIRUBIN INCREASED 110 0.0041
174 RESPIRATORY ACIDOSIS 16 0.0041
175 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
176 THROAT CLEARING 15 0.0040
177 CARDIOMYOPATHY 59 0.0040
178 LUNG NEOPLASM MALIGNANT 163 0.0040
179 FRUSTRATION TOLERANCE DECREASED 32 0.0040
180 ATRIOVENTRICULAR BLOCK SECOND DEGREE 12 0.0040
181 SINUS TACHYCARDIA 55 0.0039
182 PSYCHOTIC DISORDER 114 0.0039
183 CHOLELITHIASIS 126 0.0038
184 HYPERCHOLESTEROLAEMIA 37 0.0038
185 SLEEP APNOEA SYNDROME 73 0.0038
186 DYSENTERY 7 0.0038
187 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
188 CREPITATIONS 11 0.0037
189 PANCREATIC CYST 7 0.0037
190 RETINAL OEDEMA 7 0.0037
191 GASTROOESOPHAGEAL REFLUX DISEASE 292 0.0036
192 AFFECTIVE DISORDER 28 0.0036
193 AORTIC ARTERIOSCLEROSIS 9 0.0035
194 HYPERVENTILATION 20 0.0034
195 SNORING 13 0.0034
196 PULMONARY PAIN 10 0.0034
197 POLYMYOSITIS 6 0.0034
198 EOSINOPHILIA 59 0.0034
199 CONJUNCTIVAL HYPERAEMIA 12 0.0034
200 LOWER RESPIRATORY TRACT INFECTION 153 0.0034
201 HYPERTHERMIA MALIGNANT 5 0.0034
202 LONG QT SYNDROME 8 0.0033
203 ASTIGMATISM 5 0.0033
204 CHEST DISCOMFORT 337 0.0033
205 SNEEZING 71 0.0032
206 UPPER RESPIRATORY TRACT INFECTION 146 0.0032
207 UPPER RESPIRATORY TRACT CONGESTION 9 0.0031
208 AUTONOMIC NERVOUS SYSTEM IMBALANCE 9 0.0031
209 ABDOMINAL WALL HAEMATOMA 6 0.0031
210 BODY TEMPERATURE DECREASED 30 0.0030
211 APNOEA 23 0.0030
212 PERIPHERAL VASCULAR DISORDER 15 0.0029
213 BLOOD CHLORIDE INCREASED 5 0.0029
214 OBESITY 46 0.0029
215 MYDRIASIS 37 0.0029
216 GASTROINTESTINAL TUBE INSERTION 7 0.0028
217 APHONIA 39 0.0028
218 LIP PAIN 8 0.0028
219 RHINORRHOEA 179 0.0028
220 PHYSICAL DECONDITIONING 7 0.0027
221 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
222 PHOTOPSIA 17 0.0027
223 OXYGEN SATURATION DECREASED 150 0.0027
224 FOREIGN BODY SENSATION IN EYES 17 0.0027
225 METABOLIC ENCEPHALOPATHY 8 0.0027
226 HYPERCAPNIA 8 0.0027
227 BLOOD LOSS ANAEMIA 6 0.0026
228 ASPIRATION 29 0.0026
229 COMPLICATIONS OF TRANSPLANTED KIDNEY 6 0.0026
230 RESPIRATORY TRACT CONGESTION 42 0.0026
231 HAEMATOCRIT INCREASED 6 0.0026
232 MECHANICAL VENTILATION 5 0.0026
233 GLAUCOMA 50 0.0026
234 CONVERSION DISORDER 5 0.0026
235 RED BLOOD CELL COUNT INCREASED 7 0.0025
236 HAEMOPTYSIS 70 0.0025
237 OBSTRUCTION 10 0.0025
238 CEREBRAL THROMBOSIS 7 0.0025
239 HAEMATOLOGICAL MALIGNANCY 7 0.0025
240 EXERCISE TOLERANCE DECREASED 14 0.0024
241 MULTIPLE ALLERGIES 19 0.0024
242 DEVICE INFUSION ISSUE 6 0.0024
243 URINE OUTPUT DECREASED 21 0.0024
244 ACUTE RESPIRATORY FAILURE 46 0.0024
245 SYSTEMIC CANDIDA 6 0.0024
246 COUGH 670 0.0024
247 ATELECTASIS 23 0.0024
248 DILATATION VENTRICULAR 5 0.0024
249 MUSCLE DISORDER 19 0.0023
250 SEROTONIN SYNDROME 45 0.0023
251 ATYPICAL PNEUMONIA 7 0.0023
252 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
253 LUNG DISORDER 114 0.0023
254 HIATUS HERNIA 30 0.0023
255 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
256 MASTICATION DISORDER 7 0.0023
257 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
258 PARKINSONISM 22 0.0023
259 ARTERIOSPASM CORONARY 9 0.0022
260 TACHYCARDIA 198 0.0022
261 HYPERTHERMIA 17 0.0022
262 ANGINA PECTORIS 63 0.0022
263 CONCUSSION 17 0.0022
264 CLONUS 6 0.0022
265 ANAPHYLACTOID REACTION 9 0.0022
266 SINUS CONGESTION 29 0.0021
267 APPENDICITIS 20 0.0021
268 BRONCHITIS 158 0.0021
269 TACHYPNOEA 29 0.0021
270 ESCHERICHIA BACTERAEMIA 5 0.0021
271 BLOOD DISORDER 17 0.0021
272 OXYGEN SATURATION ABNORMAL 6 0.0021
273 ABSCESS LIMB 9 0.0021
274 HYPOTONIA 21 0.0021
275 BRONCHOSPASM 30 0.0021
276 POTENTIATING DRUG INTERACTION 7 0.0021
277 GASTROINTESTINAL OBSTRUCTION 5 0.0021
278 GASTROINTESTINAL NECROSIS 6 0.0021
279 LIGAMENT SPRAIN 20 0.0020
280 HYPOPNOEA 7 0.0020
281 URINE ABNORMALITY 9 0.0020
282 DECREASED ACTIVITY 21 0.0019
283 CHOLECYSTITIS CHRONIC 13 0.0019
284 DEPRESSED MOOD 102 0.0019
285 LUNG INFILTRATION 17 0.0019
286 PULSE ABSENT 9 0.0019
287 TRICUSPID VALVE INCOMPETENCE 15 0.0019
288 FEBRILE BONE MARROW APLASIA 8 0.0019
289 PNEUMONIA ASPIRATION 47 0.0019
290 ANKLE FRACTURE 29 0.0019
291 DYSPNOEA 1059 0.0019
292 PNEUMONIA BACTERIAL 17 0.0019
293 BLOOD TEST ABNORMAL 26 0.0018
294 VITREOUS FLOATERS 18 0.0018
295 HYPERVOLAEMIA 9 0.0018
296 PNEUMONIA 585 0.0018
297 CARDIAC FAILURE ACUTE 12 0.0018
298 BRADYCARDIA 95 0.0018
299 DISEASE RECURRENCE 85 0.0018
300 ENDOTRACHEAL INTUBATION 5 0.0018
301 UNRESPONSIVE TO STIMULI 46 0.0018
302 POSTOPERATIVE WOUND INFECTION 12 0.0018
303 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
304 PULMONARY OEDEMA 78 0.0017
305 SARS-COV-2 TEST POSITIVE 23 0.0017
306 EJECTION FRACTION DECREASED 27 0.0017
307 ENURESIS 7 0.0017
308 HEPATIC ENZYME INCREASED 118 0.0017
309 INFLUENZA 193 0.0017
310 BLADDER DISORDER 17 0.0017
311 OEDEMA PERIPHERAL 208 0.0017
312 NECROTISING FASCIITIS 6 0.0017
313 URINE ODOUR ABNORMAL 10 0.0017
314 NYSTAGMUS 9 0.0017
315 COLITIS MICROSCOPIC 8 0.0017
316 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
317 DYSTONIA 32 0.0016
318 URINARY RETENTION 55 0.0016
319 SEIZURE 190 0.0016
320 CHOKING 32 0.0016
321 ABSCESS 26 0.0016
322 VIRAL INFECTION 54 0.0016
323 ILEUS 20 0.0016
324 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
325 RESTLESS LEGS SYNDROME 29 0.0016
326 ACCIDENT 19 0.0016
327 DISCOMFORT 97 0.0016
328 FACE INJURY 6 0.0016
329 NEUROLOGICAL SYMPTOM 9 0.0016
330 SECOND PRIMARY MALIGNANCY 13 0.0016
331 DUODENAL ULCER 11 0.0016
332 INCREASED UPPER AIRWAY SECRETION 8 0.0016
333 DYSPHONIA 91 0.0016
334 PROCTALGIA 10 0.0016
335 PRODUCT SUPPLY ISSUE 11 0.0015
336 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
337 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
338 POLYP 10 0.0015
339 RESPIRATORY DISTRESS 42 0.0015
340 NEAR DEATH EXPERIENCE 5 0.0015
341 MITRAL VALVE INCOMPETENCE 17 0.0015
342 RESPIRATORY FAILURE 109 0.0015
343 SKIN ABRASION 7 0.0015
344 CARDIOGENIC SHOCK 21 0.0015
345 SCOLIOSIS 9 0.0015
346 HYPOXIA 51 0.0014
347 VITAMIN D DEFICIENCY 14 0.0014
348 LIVE BIRTH 12 0.0014
349 EXOSTOSIS 13 0.0014
350 BRAIN INJURY 14 0.0014
351 HYPOTHERMIA 14 0.0014
352 BONE DISORDER 25 0.0014
353 SENSORY DISTURBANCE 22 0.0014
354 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7 0.0014
355 TRISMUS 7 0.0014
356 FREEZING PHENOMENON 5 0.0013
357 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
358 CONJUNCTIVITIS 25 0.0013
359 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
360 CARDIAC ARREST 110 0.0013
361 NEUROPATHY PERIPHERAL 125 0.0013
362 ACIDOSIS 10 0.0013
363 BOWEL MOVEMENT IRREGULARITY 10 0.0013
364 OVERWEIGHT 7 0.0013
365 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
366 ANAL ABSCESS 7 0.0013
367 EXTRAPYRAMIDAL DISORDER 32 0.0013
368 MASS 18 0.0013
369 NASOPHARYNGITIS 237 0.0013
370 PSEUDOMONAS INFECTION 11 0.0013
371 ARTERIOSCLEROSIS 12 0.0013
372 NEUTROPHIL COUNT INCREASED 13 0.0013
373 FURUNCLE 10 0.0013
374 CEREBRAL ATROPHY 5 0.0013
375 RASH VESICULAR 6 0.0012
376 GALLBLADDER DISORDER 22 0.0012
377 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 8 0.0012
378 DELUSION 19 0.0012
379 CARDIOMEGALY 15 0.0012
380 SOMNAMBULISM 8 0.0012
381 VENTRICULAR TACHYCARDIA 20 0.0012
382 SINUSITIS 124 0.0012
383 HEART RATE INCREASED 118 0.0012
384 ENERGY INCREASED 7 0.0012
385 AORTIC ANEURYSM 9 0.0012
386 HYPOKINESIA 17 0.0012
387 DRUG INTOLERANCE 113 0.0012
388 HYPERTENSIVE CRISIS 13 0.0012
389 INJURY 82 0.0012
390 RESPIRATORY TRACT INFECTION 30 0.0012
391 POST PROCEDURAL COMPLICATION 22 0.0011
392 DEMENTIA 32 0.0011
393 MENISCUS INJURY 7 0.0011
394 SPINAL OSTEOARTHRITIS 10 0.0011
395 WEIGHT DECREASED 317 0.0011
396 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
397 RENAL PAIN 12 0.0011
398 ILLNESS 116 0.0011
399 RESPIRATORY ARREST 31 0.0011
400 CORONARY ARTERY DISEASE 34 0.0011
401 CARDIAC DISORDER 105 0.0011
402 FOOD POISONING 6 0.0011
403 ASPHYXIA 9 0.0011
404 HYDROCEPHALUS 6 0.0011
405 LIP DRY 10 0.0011
406 TYPE 2 DIABETES MELLITUS 37 0.0011
407 JAW DISORDER 6 0.0011
408 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
409 MUSCLE RIGIDITY 13 0.0011
410 EAR PAIN 21 0.0011
411 FEELING COLD 30 0.0011
412 NODULE 14 0.0011
413 DRUG ERUPTION 19 0.0011
414 CONDITION AGGRAVATED 325 0.0011
415 DISABILITY 21 0.0011
416 NEUTROPHILIA 6 0.0011
417 HYPERTONIA 6 0.0010
418 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
419 PARANOIA 18 0.0010
420 QUALITY OF LIFE DECREASED 14 0.0010
421 PROCEDURAL COMPLICATION 8 0.0010
422 COLITIS ISCHAEMIC 7 0.0010
423 BLOOD PRESSURE INCREASED 158 0.0010
424 BODY TEMPERATURE INCREASED 21 0.0010
425 PNEUMONITIS 28 0.0010
426 PELVIC FRACTURE 8 0.0010
427 PERIPHERAL COLDNESS 14 0.0010
428 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
429 HOSPICE CARE 10 0.0010
430 HALLUCINATION 76 0.0010
431 PARAESTHESIA 157 0.0010
432 THERAPEUTIC RESPONSE SHORTENED 33 0.0010
433 DEVICE OCCLUSION 14 0.0010
434 LACRIMATION INCREASED 30 0.0010
435 MYASTHENIA GRAVIS 8 0.0010
436 ADRENAL INSUFFICIENCY 12 0.0010
437 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
438 SKIN LESION 27 0.0010
439 DRY THROAT 10 0.0010
440 DECUBITUS ULCER 8 0.0010
441 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
442 HELICOBACTER INFECTION 10 0.0010
443 PARAESTHESIA ORAL 14 0.0010
444 TONGUE DISORDER 7 0.0010
445 MYOCARDIAL ISCHAEMIA 11 0.0010
446 BACTERIAL INFECTION 18 0.0010
447 INFUSION SITE EXTRAVASATION 6 0.0010
448 PRODUCT USE IN UNAPPROVED INDICATION 238 0.0010
449 SINUS DISORDER 19 0.0010
450 INJECTION SITE DISCOMFORT 10 0.0009
451 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
452 MUSCLE ATROPHY 12 0.0009
453 SEPTIC SHOCK 41 0.0009
454 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
455 RIB FRACTURE 19 0.0009
456 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
457 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
458 HEPATOMEGALY 9 0.0009
459 OESOPHAGITIS 10 0.0009
460 PRODUCT PREPARATION ISSUE 6 0.0009
461 WOUND INFECTION 10 0.0009
462 URINARY INCONTINENCE 27 0.0009
463 ORAL CANDIDIASIS 12 0.0009
464 STAPHYLOCOCCAL INFECTION 30 0.0009
465 CHOKING SENSATION 5 0.0009
466 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
467 VENTRICULAR FIBRILLATION 10 0.0009
468 PYREXIA 311 0.0009
469 MALNUTRITION 10 0.0009
470 GASTROINTESTINAL INFLAMMATION 7 0.0009
471 BREAST MASS 6 0.0009
472 ANAL INCONTINENCE 8 0.0009
473 PNEUMOTHORAX 14 0.0009
474 POOR QUALITY SLEEP 19 0.0009
475 MATERNAL EXPOSURE BEFORE PREGNANCY 6 0.0009
476 INFECTION 127 0.0009
477 DIABETES MELLITUS 66 0.0009
478 FALL 288 0.0009
479 OROPHARYNGEAL PAIN 80 0.0009
480 BRADYKINESIA 5 0.0008
481 LIMB INJURY 23 0.0008
482 SPINAL COMPRESSION FRACTURE 7 0.0008
483 SEDATION 22 0.0008
484 CATARACT 50 0.0008
485 DRUG INTERACTION 133 0.0008
486 PRODUCT AVAILABILITY ISSUE 19 0.0008
487 ANAPHYLACTIC REACTION 46 0.0008
488 MALAISE 365 0.0008
489 SKIN PLAQUE 7 0.0008
490 MENTAL STATUS CHANGES 23 0.0008
491 HEART RATE DECREASED 29 0.0008
492 PANIC ATTACK 30 0.0008
493 RENAL TUBULAR NECROSIS 8 0.0008
494 KIDNEY INFECTION 16 0.0008
495 MUSCLE SPASTICITY 10 0.0008
496 ARTHRITIS 64 0.0008
497 MUSCULOSKELETAL DISCOMFORT 14 0.0008
498 SMALL INTESTINAL OBSTRUCTION 10 0.0008
499 PRODUCT TASTE ABNORMAL 11 0.0008
500 PHARYNGITIS 10 0.0008
501 ACUTE HEPATIC FAILURE 11 0.0008
502 UPPER LIMB FRACTURE 16 0.0008
503 HYPERSOMNIA 23 0.0008
504 RESTLESSNESS 29 0.0008
505 HEAD INJURY 25 0.0008
506 HYPOAESTHESIA 117 0.0008
507 MENTAL DISORDER 34 0.0008
508 COAGULOPATHY 13 0.0008
509 THROAT IRRITATION 35 0.0008
510 THYROID DISORDER 12 0.0008
511 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
512 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 140 0.0008
513 MATERNAL EXPOSURE DURING PREGNANCY 69 0.0008
514 CARDIAC FAILURE 62 0.0008
515 PETECHIAE 8 0.0008
516 WEIGHT FLUCTUATION 8 0.0008
517 SPEECH DISORDER 40 0.0008
518 ASPERGILLUS INFECTION 5 0.0008
519 DYSURIA 28 0.0008
520 GRAND MAL CONVULSION 7 0.0008
521 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
522 MYOCLONUS 9 0.0008
523 BLOOD PRESSURE ABNORMAL 15 0.0008
524 DYSSTASIA 22 0.0008
525 HYPOTENSION 151 0.0008
526 OCULAR HYPERAEMIA 35 0.0007
527 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
528 SHOCK HAEMORRHAGIC 6 0.0007
529 ANAPHYLACTIC SHOCK 19 0.0007
530 BACK INJURY 8 0.0007
531 INFARCTION 5 0.0007
532 CHEST PAIN 135 0.0007
533 EYE PAIN 41 0.0007
534 CYST 9 0.0007
535 OSTEOPENIA 11 0.0007
536 EXPOSURE DURING PREGNANCY 45 0.0007
537 MOBILITY DECREASED 52 0.0007
538 HUNGER 10 0.0007
539 HYPERTENSION 152 0.0007
540 HYPERHIDROSIS 92 0.0007
541 END STAGE RENAL DISEASE 13 0.0007
542 MUSCULAR WEAKNESS 81 0.0007
543 LETHARGY 41 0.0007
544 HALLUCINATION, VISUAL 15 0.0007
545 FEMUR FRACTURE 22 0.0007
546 LUNG INFECTION 11 0.0007
547 FEAR 19 0.0007
548 DYSPHAGIA 67 0.0007
549 HAND FRACTURE 5 0.0007
550 EATING DISORDER 15 0.0007
551 SWOLLEN TONGUE 22 0.0007
552 THROAT TIGHTNESS 19 0.0007
553 INTENTIONAL DOSE OMISSION 20 0.0007
554 DERMATITIS CONTACT 8 0.0007
555 METASTASIS 5 0.0007
556 FIBROMYALGIA 17 0.0007
557 PARALYSIS 10 0.0007
558 THERAPY NON-RESPONDER 31 0.0007
559 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
560 METABOLIC ACIDOSIS 22 0.0007
561 FAECES SOFT 5 0.0007
562 TOOTH ABSCESS 7 0.0007
563 GASTROENTERITIS 10 0.0007
564 BLOOD CALCIUM INCREASED 6 0.0007
565 WEIGHT INCREASED 153 0.0007
566 EAR DISCOMFORT 7 0.0007
567 NECK PAIN 38 0.0007
568 HERPES ZOSTER 39 0.0007
569 ACUTE MYOCARDIAL INFARCTION 20 0.0007
570 PURPURA 6 0.0007
571 HEAD DISCOMFORT 12 0.0007
572 PULMONARY FIBROSIS 13 0.0007
573 ARTHROPOD BITE 5 0.0007
574 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
575 FACIAL PAIN 6 0.0007
576 HYPERLIPIDAEMIA 8 0.0007
577 BLOOD PRESSURE FLUCTUATION 16 0.0007
578 SCRATCH 7 0.0007
579 GAIT DISTURBANCE 127 0.0007
580 INTESTINAL OBSTRUCTION 25 0.0007
581 LEUKOCYTOSIS 12 0.0007
582 PULMONARY EMBOLISM 63 0.0007
583 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
584 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
585 GAIT INABILITY 22 0.0007
586 HIDRADENITIS 6 0.0007
587 OSTEOPOROSIS 27 0.0007
588 CELLULITIS 33 0.0007
589 BODY HEIGHT DECREASED 7 0.0007
590 INSURANCE ISSUE 10 0.0007
591 DRY MOUTH 53 0.0007
592 INSOMNIA 173 0.0006
593 RASH ERYTHEMATOUS 31 0.0006
594 LIMB DISCOMFORT 20 0.0006
595 FULL BLOOD COUNT DECREASED 13 0.0006
596 SKIN LACERATION 7 0.0006
597 ASTHENIA 242 0.0006
598 AGITATION 47 0.0006
599 HOSPITALISATION 98 0.0006
600 ATRIAL FIBRILLATION 62 0.0006
601 GASTROINTESTINAL PAIN 7 0.0006
602 PRODUCT USE COMPLAINT 10 0.0006
603 ARRHYTHMIA 30 0.0006
604 CHILLS 74 0.0006
605 FREQUENT BOWEL MOVEMENTS 17 0.0006
606 HYPOTHYROIDISM 20 0.0006
607 DISEASE PROGRESSION 74 0.0006
608 COLD SWEAT 11 0.0006
609 OCULAR DISCOMFORT 7 0.0006
610 SINUS BRADYCARDIA 6 0.0006
611 STATUS EPILEPTICUS 7 0.0006
612 DIPLOPIA 16 0.0006
613 BACK DISORDER 10 0.0006
614 PLATELET COUNT INCREASED 8 0.0006
615 CARDIAC FAILURE CONGESTIVE 49 0.0006
616 WOUND 17 0.0006
617 PLEURAL EFFUSION 37 0.0006
618 HYPOKALAEMIA 28 0.0006
619 HAEMOGLOBIN DECREASED 62 0.0006
620 HYPERSENSITIVITY 112 0.0006
621 CONTUSION 58 0.0006
622 EMBOLISM 5 0.0006
623 EAR INFECTION 16 0.0006
624 INTERSTITIAL LUNG DISEASE 29 0.0006
625 SPINAL PAIN 7 0.0006
626 SOMNOLENCE 120 0.0006
627 MYALGIA 101 0.0006
628 VOMITING 278 0.0006
629 BALANCE DISORDER 51 0.0006
630 BLOOD IRON DECREASED 7 0.0006
631 NEUTROPHIL COUNT DECREASED 24 0.0006
632 FEBRILE NEUTROPENIA 39 0.0006
633 GENERAL PHYSICAL HEALTH DETERIORATION 68 0.0006
634 HYPOPHAGIA 15 0.0006
635 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
636 LYMPHOMA 9 0.0006
637 MUSCULOSKELETAL CHEST PAIN 9 0.0006
638 SKIN ULCER 15 0.0006
639 POOR VENOUS ACCESS 6 0.0006
640 BLOOD MAGNESIUM DECREASED 5 0.0006
641 HYSTERECTOMY 5 0.0006
642 DELIRIUM 20 0.0006
643 TENDERNESS 6 0.0006
644 HEART RATE IRREGULAR 13 0.0006
645 ORTHOSTATIC HYPOTENSION 10 0.0006
646 CONSTIPATION 125 0.0006
647 RESPIRATORY DEPRESSION 7 0.0006
648 URINARY TRACT INFECTION 97 0.0006
649 PRESCRIBED OVERDOSE 11 0.0006
650 SKIN REACTION 8 0.0006
651 INCONTINENCE 6 0.0006
652 DYSKINESIA 23 0.0006
653 PREMATURE DELIVERY 9 0.0006
654 IMPAIRED QUALITY OF LIFE 8 0.0006
655 DEHYDRATION 74 0.0006
656 TREMOR 92 0.0006
657 ECZEMA 29 0.0006
658 HAEMATEMESIS 14 0.0006
659 RHABDOMYOLYSIS 23 0.0006
660 PULMONARY THROMBOSIS 6 0.0005
661 HYPERGLYCAEMIA 20 0.0005
662 GASTROINTESTINAL DISORDER 49 0.0005
663 ABDOMINAL DISTENSION 57 0.0005
664 TASTE DISORDER 11 0.0005
665 HYPERKALAEMIA 19 0.0005
666 PROCEDURAL PAIN 15 0.0005
667 AMNESIA 35 0.0005
668 ANXIETY 153 0.0005
669 MUSCULOSKELETAL PAIN 28 0.0005
670 BLOOD CALCIUM DECREASED 6 0.0005
671 ANHEDONIA 14 0.0005
672 COVID-19 93 0.0005
673 APHASIA 16 0.0005
674 HIP FRACTURE 17 0.0005
675 PULMONARY HYPERTENSION 11 0.0005
676 SCAB 6 0.0005
677 ROAD TRAFFIC ACCIDENT 22 0.0005
678 CHOLECYSTECTOMY 6 0.0005
679 MUSCULOSKELETAL STIFFNESS 46 0.0005
680 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
681 INFLUENZA LIKE ILLNESS 43 0.0005
682 ELECTROLYTE IMBALANCE 6 0.0005
683 RENAL IMPAIRMENT 43 0.0005
684 ABDOMINAL DISCOMFORT 85 0.0005
685 PERIPHERAL SWELLING 78 0.0005
686 FEELING HOT 31 0.0005
687 ISCHAEMIC STROKE 9 0.0005
688 CHOLECYSTITIS 6 0.0005
689 ACUTE KIDNEY INJURY 77 0.0005
690 NEPHROLITHIASIS 23 0.0005
691 CARPAL TUNNEL SYNDROME 7 0.0005
692 OSTEOMYELITIS 9 0.0005
693 SLEEP DISORDER 35 0.0005
694 BONE PAIN 29 0.0005
695 RASH MACULO-PAPULAR 11 0.0005
696 PRODUCT DOSE OMISSION ISSUE 145 0.0005
697 VISUAL IMPAIRMENT 61 0.0005
698 MOTOR DYSFUNCTION 5 0.0005
699 SUBDURAL HAEMATOMA 7 0.0005
700 EYE DISORDER 16 0.0005
701 PAIN IN EXTREMITY 143 0.0005
702 GENERALISED OEDEMA 6 0.0005
703 MYELODYSPLASTIC SYNDROME 7 0.0005
704 COMA 23 0.0005
705 FATIGUE 376 0.0005
706 BLOOD PRESSURE DECREASED 32 0.0005
707 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
708 HYPONATRAEMIA 27 0.0005
709 PHOTOPHOBIA 9 0.0005
710 DERMATITIS ALLERGIC 6 0.0005
711 SEPSIS 53 0.0005
712 FOOT FRACTURE 9 0.0005
713 CHRONIC KIDNEY DISEASE 36 0.0005
714 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
715 CYSTITIS 15 0.0005
716 CONFUSIONAL STATE 76 0.0005
717 CRYING 17 0.0005
718 DRUG DEPENDENCE 75 0.0005
719 HERNIA 9 0.0005
720 ECONOMIC PROBLEM 7 0.0005
721 LOSS OF CONSCIOUSNESS 59 0.0005
722 DRUG DISPENSING ERROR 7 0.0005
723 PRODUCT USE ISSUE 86 0.0005
724 GASTRITIS 12 0.0005
725 IMMUNE SYSTEM DISORDER 6 0.0005
726 DEVICE RELATED INFECTION 7 0.0005
727 LYMPHOCYTE COUNT DECREASED 8 0.0005
728 MIGRAINE 43 0.0004
729 DRY SKIN 60 0.0004
730 NEOPLASM MALIGNANT 30 0.0004
731 THERAPY PARTIAL RESPONDER 7 0.0004
732 ORAL PAIN 10 0.0004
733 NEEDLE ISSUE 13 0.0004
734 DIZZINESS 222 0.0004
735 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
736 RENAL FAILURE 59 0.0004
737 FEEDING DISORDER 9 0.0004
738 GASTROENTERITIS VIRAL 8 0.0004
739 OFF LABEL USE 387 0.0004
740 ANAEMIA 84 0.0004
741 UNDERDOSE 32 0.0004
742 HAEMATURIA 15 0.0004
743 MICTURITION URGENCY 5 0.0004
744 ARTHRALGIA 182 0.0004
745 CORONARY ARTERY OCCLUSION 6 0.0004
746 MYOCARDITIS 5 0.0004
747 HYPOMAGNESAEMIA 6 0.0004
748 NAUSEA 340 0.0004
749 DEPRESSION 97 0.0004
750 DYSARTHRIA 16 0.0004
751 FRACTURE 8 0.0004
752 VISION BLURRED 58 0.0004
753 JOINT INJURY 9 0.0004
754 IRRITABLE BOWEL SYNDROME 9 0.0004
755 CONVULSION 24 0.0004
756 BACK PAIN 97 0.0004
757 PRODUCT SUBSTITUTION ISSUE 24 0.0004
758 CANDIDA INFECTION 7 0.0004
759 HYPERTHYROIDISM 6 0.0004
760 FEELING ABNORMAL 99 0.0004
761 PRODUCT PRESCRIBING ISSUE 9 0.0004
762 SCAR 7 0.0004
763 LIVER INJURY 10 0.0004
764 ENCEPHALOPATHY 10 0.0004
765 CARDIO-RESPIRATORY ARREST 17 0.0004
766 RENAL INJURY 12 0.0004
767 HAEMATOCRIT DECREASED 8 0.0004
768 EYE SWELLING 15 0.0004
769 IMMUNODEFICIENCY 6 0.0004
770 PANCREATITIS ACUTE 9 0.0004
771 MEMORY IMPAIRMENT 55 0.0004
772 SPINAL FRACTURE 8 0.0004
773 DIVERTICULITIS 11 0.0004
774 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
775 ABDOMINAL PAIN 92 0.0004
776 CARDIOVASCULAR DISORDER 10 0.0004
777 HYPOGLYCAEMIA 19 0.0004
778 INTRAOCULAR PRESSURE INCREASED 5 0.0004
779 SKIN DISORDER 13 0.0004
780 DRUG RESISTANCE 10 0.0004
781 INFUSION SITE PAIN 5 0.0004
782 THROMBOCYTOPENIA 43 0.0004
783 IRRITABILITY 23 0.0004
784 DEAFNESS 10 0.0004
785 BEDRIDDEN 5 0.0004
786 ULCER 6 0.0004
787 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
788 JAUNDICE 10 0.0004
789 LACTIC ACIDOSIS 12 0.0004
790 MUSCLE TIGHTNESS 6 0.0004
791 OEDEMA 20 0.0004
792 OSTEONECROSIS OF JAW 9 0.0004
793 MELAENA 8 0.0004
794 MYOCARDIAL INFARCTION 63 0.0004
795 PRURITUS 138 0.0004
796 HAEMORRHOIDS 7 0.0004
797 URTICARIA 60 0.0004
798 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
799 CHROMATURIA 8 0.0004
800 BLOOD GLUCOSE DECREASED 17 0.0004
801 HAEMORRHAGE 37 0.0004
802 OSTEOARTHRITIS 15 0.0004
803 ABNORMAL BEHAVIOUR 14 0.0004
804 INJECTION SITE MASS 13 0.0004
805 EPISTAXIS 26 0.0003
806 MULTI-ORGAN FAILURE 6 0.0003
807 MUSCLE TWITCHING 8 0.0003
808 DIARRHOEA 224 0.0003
809 HEADACHE 217 0.0003
810 DYSPEPSIA 34 0.0003
811 ANOSMIA 5 0.0003
812 ADVERSE DRUG REACTION 31 0.0003
813 HOT FLUSH 26 0.0003
814 RASH MACULAR 12 0.0003
815 DEVICE USE ISSUE 6 0.0003
816 SYRINGE ISSUE 6 0.0003
817 INCORRECT DOSE ADMINISTERED 78 0.0003
818 DRUG INEFFECTIVE 450 0.0003
819 LYMPHADENOPATHY 12 0.0003
820 THIRST 6 0.0003
821 POLLAKIURIA 14 0.0003
822 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
823 BLOOD POTASSIUM DECREASED 10 0.0003
824 PREMATURE BABY 10 0.0003
825 ABDOMINAL PAIN UPPER 68 0.0003
826 BLOOD COUNT ABNORMAL 5 0.0003
827 VERTIGO 20 0.0003
828 DEATH 282 0.0003
829 ABORTION SPONTANEOUS 13 0.0003
830 DEEP VEIN THROMBOSIS 21 0.0003
831 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
832 COGNITIVE DISORDER 15 0.0003
833 SWELLING 30 0.0003
834 BLISTER 18 0.0003
835 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
836 SYNCOPE 32 0.0003
837 CYANOSIS 5 0.0003
838 UNEVALUABLE EVENT 24 0.0003
839 MUSCLE SPASMS 58 0.0003
840 PALPITATIONS 37 0.0003
841 GASTRIC ULCER 6 0.0003
842 DISTURBANCE IN ATTENTION 17 0.0003
843 RED BLOOD CELL COUNT DECREASED 9 0.0003
844 MOVEMENT DISORDER 10 0.0003
845 DECREASED APPETITE 72 0.0003
846 HAEMATOMA 8 0.0003
847 CEREBRAL HAEMORRHAGE 11 0.0003
848 SURGERY 18 0.0003
849 TINNITUS 14 0.0003
850 SHOCK 7 0.0003
851 PERICARDIAL EFFUSION 7 0.0003
852 PANCREATITIS 16 0.0003
853 INJECTION SITE BRUISING 24 0.0003
854 PRESCRIBED UNDERDOSE 6 0.0003
855 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
856 LIP SWELLING 10 0.0003
857 PRODUCT ADMINISTRATION ERROR 6 0.0003
858 THERAPEUTIC RESPONSE DECREASED 18 0.0003
859 FACE OEDEMA 5 0.0003
860 HEMIPARESIS 5 0.0003
861 PRODUCT PRESCRIBING ERROR 7 0.0003
862 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
863 INFLAMMATION 15 0.0003
864 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
865 PAIN 178 0.0003
866 LOCALISED INFECTION 7 0.0003
867 TARDIVE DYSKINESIA 8 0.0003
868 RENAL FAILURE ACUTE 12 0.0003
869 PAIN IN JAW 8 0.0003
870 RETCHING 6 0.0003
871 NIGHT SWEATS 9 0.0003
872 DISORIENTATION 11 0.0003
873 ERYTHEMA 57 0.0003
874 BLOOD CREATININE INCREASED 18 0.0003
875 C-REACTIVE PROTEIN INCREASED 10 0.0003
876 JOINT SWELLING 33 0.0003
877 EMOTIONAL DISTRESS 33 0.0003
878 ASCITES 8 0.0003
879 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 55 0.0003
880 TOOTH DISORDER 6 0.0003
881 EYE PRURITUS 9 0.0003
882 EPILEPSY 8 0.0003
883 LOWER LIMB FRACTURE 5 0.0003
884 DRUG PRESCRIBING ERROR 5 0.0003
885 NERVOUS SYSTEM DISORDER 8 0.0003
886 HYPOACUSIS 11 0.0003
887 NERVOUSNESS 13 0.0002
888 CEREBROVASCULAR ACCIDENT 42 0.0002
889 NEURALGIA 6 0.0002
890 COLITIS ULCERATIVE 11 0.0002
891 SWELLING FACE 16 0.0002
892 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
893 AGEUSIA 6 0.0002
894 DRY EYE 12 0.0002
895 FUNGAL INFECTION 8 0.0002
896 LEUKOPENIA 12 0.0002
897 AGGRESSION 12 0.0002
898 COLITIS 9 0.0002
899 MOUTH ULCERATION 5 0.0002
900 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
901 PRODUCT COMPLAINT 6 0.0002
902 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
903 GASTRIC DISORDER 8 0.0002
904 HEPATIC FAILURE 7 0.0002
905 FAECES DISCOLOURED 5 0.0002
906 RASH 100 0.0002
907 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
908 JOINT STIFFNESS 6 0.0002
909 NEUTROPENIA 31 0.0002
910 DERMATITIS ATOPIC 12 0.0002
911 FLUSHING 23 0.0002
912 LIVER DISORDER 10 0.0002
913 THERAPY INTERRUPTED 16 0.0002
914 RASH PRURITIC 12 0.0002
915 PALLOR 6 0.0002
916 FLUID RETENTION 11 0.0002
917 RENAL DISORDER 10 0.0002
918 BLOOD CHOLESTEROL INCREASED 10 0.0002
919 DEVICE MALFUNCTION 15 0.0002
920 FLATULENCE 12 0.0002
921 INJECTION SITE PAIN 64 0.0002
922 EYE IRRITATION 12 0.0002
923 TOXICITY TO VARIOUS AGENTS 35 0.0002
924 ANGER 7 0.0002
925 ABASIA 5 0.0002
926 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
927 BURNING SENSATION 14 0.0002
928 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
929 EXTRA DOSE ADMINISTERED 8 0.0002
930 GASTRIC CANCER 5 0.0002
931 SUICIDAL IDEATION 18 0.0002
932 SKIN DISCOLOURATION 9 0.0002
933 INJECTION SITE RASH 6 0.0002
934 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
935 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
936 PRODUCT QUALITY ISSUE 26 0.0002
937 SKIN EXFOLIATION 16 0.0002
938 INJECTION SITE REACTION 13 0.0002
939 VAGINAL HAEMORRHAGE 8 0.0002
940 MOOD ALTERED 5 0.0002
941 MEDICATION ERROR 10 0.0002
942 DEVICE ISSUE 16 0.0002
943 OVERDOSE 38 0.0002
944 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
945 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
946 INJECTION SITE HAEMORRHAGE 14 0.0002
947 THROMBOSIS 14 0.0002
948 NIGHTMARE 6 0.0002
949 LIVER FUNCTION TEST ABNORMAL 5 0.0002
950 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
951 ILL-DEFINED DISORDER 10 0.0002
952 TREATMENT NONCOMPLIANCE 9 0.0002
953 HAEMATOCHEZIA 9 0.0002
954 EMOTIONAL DISORDER 5 0.0002
955 PANCYTOPENIA 9 0.0002
956 DEVICE DISLOCATION 7 0.0002
957 BONE DENSITY DECREASED 5 0.0002
958 RHEUMATOID ARTHRITIS 18 0.0002
959 PSORIASIS 19 0.0001
960 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
961 WITHDRAWAL SYNDROME 6 0.0001
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
963 DEVICE LEAKAGE 6 0.0001
964 INFUSION RELATED REACTION 9 0.0001
965 ANGIOEDEMA 6 0.0001
966 STOMATITIS 8 0.0001
967 ACNE 10 0.0001
968 PLATELET COUNT DECREASED 14 0.0001
969 SKIN IRRITATION 6 0.0001
970 DRUG EFFECT DECREASED 7 0.0001
971 NO ADVERSE EVENT 23 0.0001
972 COLORECTAL CANCER 6 0.0001
973 MULTIPLE SCLEROSIS 6 0.0001
974 DYSGEUSIA 9 0.0001
975 INJECTION SITE SWELLING 9 0.0001
976 BLOOD GLUCOSE INCREASED 22 0.0001
977 ALOPECIA 22 0.0001
978 ADVERSE EVENT 10 0.0001
979 DRUG ABUSE 9 0.0001
980 ARTHROPATHY 6 0.0001
981 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
982 INJECTION SITE PRURITUS 7 0.0001
983 SUICIDE ATTEMPT 6 0.0001
984 INTENTIONAL PRODUCT MISUSE 8 0.0001
985 DRUG WITHDRAWAL SYNDROME 8 0.0001
986 PROSTATE CANCER 6 0.0001
987 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
988 INJECTION SITE ERYTHEMA 9 0.0001
989 PRODUCT STORAGE ERROR 6 0.0001
990 DRUG DOSE OMISSION 8 0.0000